Open access
Aug 2026
From TD50 to Benchmark Dose in Nitrosamine Risk Assessment: Evidence from N-Nitrosotrimetazidine Carcinogenicity and TGR Mutation Data
Mélanie Leheup Foucaud, G. Johnson, D. Kirkland et al.
· bioRxiv · 0 citations